Lv1
46 积分 2024-09-24 加入
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
16小时前
已完结
Usage of a split CH2 domain as building block for new antibody formats
5天前
已完结
Strategy for streamlining antibody–drug conjugate pharmacokinetic assays
6天前
已完结
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
8天前
已完结
POS0375 ASSESSMENT OF S95011 (OSE-127, LUSVERTIKIMAB), AN ANTI-INTERLEUKIN 7 RECEPTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: AN INTERNATIONAL MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY
12天前
已完结
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα
12天前
已完结
Off-target reactivity in clinical monoclonal antibodies
14天前
已完结
A Road Map to GMP Readiness for Protein Therapeutics – Drug Product Process Development for Clinical Supply
26天前
已完结
Multi-attribute methods in antibody-drug conjugate characterization and quality control: Opportunities, challenges, and regulatory outlook
1个月前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
1个月前
已完结
皖公网安备34019202002308
